229 related articles for article (PubMed ID: 22031318)
1. Myxoid adrenocortical neoplasms: a study of the clinicopathologic features and EGFR gene status of ten Chinese cases.
Zhang J; Sun J; Liang Z; Gao J; Zeng X; Liu T
Am J Clin Pathol; 2011 Nov; 136(5):783-92. PubMed ID: 22031318
[TBL] [Abstract][Full Text] [Related]
2. Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior.
Papotti M; Volante M; Duregon E; Delsedime L; Terzolo M; Berruti A; Rosai J
Am J Surg Pathol; 2010 Jul; 34(7):973-83. PubMed ID: 20534995
[TBL] [Abstract][Full Text] [Related]
3. Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy.
Velázquez-Fernández D; Laurell C; Geli J; Höög A; Odeberg J; Kjellman M; Lundeberg J; Hamberger B; Nilsson P; Bäckdahl M
Surgery; 2005 Dec; 138(6):1087-94. PubMed ID: 16360395
[TBL] [Abstract][Full Text] [Related]
4. Adrenal cortical neoplasms: a study of clinicopathological features related to epidermal growth factor receptor gene status.
Zhang J; Wang C; Gao J; Sun J; Zeng X; Wu S; Liang Z
Diagn Pathol; 2014 Jan; 9():19. PubMed ID: 24457059
[TBL] [Abstract][Full Text] [Related]
5. Myxoid adrenal cortical neoplasms.
Raparia K; Ayala AG; Sienko A; Zhai QJ; Ro JY
Ann Diagn Pathol; 2008 Oct; 12(5):344-8. PubMed ID: 18774497
[TBL] [Abstract][Full Text] [Related]
6. Nestin as a marker in the classification of adrenocortical tumors.
Lachenmayer A; Lichtenauer UD; Cox T; Schott M; Malendowicz LK; Goretzki PE; Cupisti K; Scherbaum WA; Bornstein SR; Willenberg HS
Horm Metab Res; 2009 May; 41(5):397-401. PubMed ID: 19294612
[TBL] [Abstract][Full Text] [Related]
7. Analysis of genomic alterations in sporadic adrenocortical lesions. Gain of chromosome 17 is an early event in adrenocortical tumorigenesis.
Zhao J; Speel EJ; Muletta-Feurer S; Rütimann K; Saremaslani P; Roth J; Heitz PU; Komminoth P
Am J Pathol; 1999 Oct; 155(4):1039-45. PubMed ID: 10514385
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling in adrenocortical neoplasia.
Assie G; Giordano TJ; Bertherat J
Mol Cell Endocrinol; 2012 Mar; 351(1):111-7. PubMed ID: 22056416
[TBL] [Abstract][Full Text] [Related]
9. Molecular markers and the pathogenesis of adrenocortical cancer.
Soon PS; McDonald KL; Robinson BG; Sidhu SB
Oncologist; 2008 May; 13(5):548-61. PubMed ID: 18515740
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathologic features and expression of epidermal growth factor receptor and vascular endothelial growth factor in adrenocortical tumors].
Wang CP; Zhang J; Gao J; Liu PP; Wu SF; Zeng X; Liang ZY
Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):686-90. PubMed ID: 23302311
[TBL] [Abstract][Full Text] [Related]
11. Myxoid adrenocortical carcinoma: a clinicopathologic and immunohistochemical study of 7 cases, including 1 case with lipomatous metaplasia.
Weissferdt A; Phan A; Suster S; Moran CA
Am J Clin Pathol; 2013 Jun; 139(6):780-6. PubMed ID: 23690121
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling of childhood adrenocortical tumors.
West AN; Neale GA; Pounds S; Figueredo BC; Rodriguez Galindo C; Pianovski MA; Oliveira Filho AG; Malkin D; Lalli E; Ribeiro R; Zambetti GP
Cancer Res; 2007 Jan; 67(2):600-8. PubMed ID: 17234769
[TBL] [Abstract][Full Text] [Related]
13. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J
Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927
[TBL] [Abstract][Full Text] [Related]
14. Cytological features of myxoid adrenocortical adenoma with a pseudoglandular component: a case report with differential diagnostic considerations.
Ishida M; Yoshida K; Miyamoto K; Iwai M; Miyahira Y; Kushima R; Okabe H
Diagn Cytopathol; 2008 Aug; 36(8):576-80. PubMed ID: 18618725
[TBL] [Abstract][Full Text] [Related]
15. Myxoid neoplasms of the adrenal cortex: a rare histologic variant.
Brown FM; Gaffey TA; Wold LE; Lloyd RV
Am J Surg Pathol; 2000 Mar; 24(3):396-401. PubMed ID: 10716153
[TBL] [Abstract][Full Text] [Related]
16. Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations.
Durand J; Lampron A; Mazzuco TL; Chapman A; Bourdeau I
J Clin Endocrinol Metab; 2011 Jul; 96(7):E1206-11. PubMed ID: 21565795
[TBL] [Abstract][Full Text] [Related]
17. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression.
Willmore-Payne C; Holden JA; Layfield LJ
Hum Pathol; 2006 Jun; 37(6):755-63. PubMed ID: 16733218
[TBL] [Abstract][Full Text] [Related]
18. Protein overexpression and gene amplification of epidermal growth factor receptor in adult testicular germ cell tumors: potential role in tumor progression.
Miyai K; Yamamoto S; Asano T; Tamai S; Matsubara O; Tsuda H
Cancer Sci; 2010 Sep; 101(9):1970-6. PubMed ID: 20608935
[TBL] [Abstract][Full Text] [Related]
19. Steroidogenic factor 1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults.
Almeida MQ; Soares IC; Ribeiro TC; Fragoso MC; Marins LV; Wakamatsu A; Ressio RA; Nishi MY; Jorge AA; Lerario AM; Alves VA; Mendonca BB; Latronico AC
J Clin Endocrinol Metab; 2010 Mar; 95(3):1458-62. PubMed ID: 20080844
[TBL] [Abstract][Full Text] [Related]
20. Image cytometric DNA analysis of adrenocortical neoplasms as a prognostic parameter: a clinico-pathologic study of 13 patients.
Lü X; Stallmach T; Gebbers JO
Anal Cell Pathol; 1996 Oct; 12(1):1-11. PubMed ID: 8933905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]